This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit May. 17, 2012

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Click Here to view the Journal of Managed Care Medicine

Online CME/CEU Programs
Multiple Myeloma: An Update on Diagnostic and Treatment Strategies

Advanced Treatment of Osteoporosis in Postmenopausal Women

Decreasing the Cost Burden of Fibromyalgia with Early Diagnosis and Management

Announcing the NAMCP Medical Directors Lung Cancer Resource Center. Click here to visit the website.

Be sure to check out the study results of Verinata's Non-Invasive Prenatal Technology. Click here to view the press release.

Click here to check out the "Latest in Clinical Nutrition" DVD available for purchase now!

Save the Date:
Fall Managed Care Forum
November 8-9
Bellagio Hotel



Genes might be key to Parkinson's spread
HealthDay News via MSN    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers have identified gene variants that speed the progression of Parkinson's disease, and they say their findings could help identify patients who would benefit most from early treatment. The University of California-Los Angeles researchers say their findings also may help efforts to develop new therapies. More

What is the Health Economic Impact of a Non-Invasive Prenatal Test?

Learn About Bridgehead International’s report, authored by Susan Garfield, on the clinical and economic utility of this test in this quarter’s JMCM, entitled “Clinical and Cost Consequences of Incorporating a Novel Non-Invasive Prenatal Test into the Diagnostic Pathway for Fetal Trisomies.

Weight-loss surgery trigged rare genetic wasting disorder
The Tennessean via USA Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
While a gastric bypass can help severely obese people maintain a healthier weight and in some cases even cure diabetes, the surgery has its own set of risks. The death rate from the actual surgery is less than 1 percent, but complications can occur later, ranging from calcium malabsorption to a rare genetic disorder that killed a Tennessee woman. More

Researchers identify genes, prototype predictive test for schizophrenia
Bioscience Technology    Share    Share on FacebookTwitterShare on LinkedinE-mail article
An Indiana University-led research team, along with a group of national and international collaborators, has identified and prioritized a comprehensive group of genes most associated with schizophrenia that together can generate a score indicating whether an individual is at higher or lower risk of developing the disease. More

 Biotech/Diagnostics/Personalized Medicine

Clock ticking on Alzheimer's treatment stratgey
The Associated Press via The Washington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
President Barack Obama's administration recently declared Alzheimer's one of the country's biggest health challenges, adopting a national strategy that sets the clock ticking toward better treatments by 2025 — along with help for suffering families today. More

A new dimension to DNA and personalized medicine of the future
PhysOrg    Share    Share on FacebookTwitterShare on LinkedinE-mail article
By investigating the existence of an unusual four-stranded structure of DNA in human cells, scientists have opened the door to novel cancer therapeutics and a new era for personalized medicine. At the heart of the new discovery is an innovative way of locating the structures in living cells and then "capturing" them for further examination. More


Nursing@Georgetown is a Master’s in Nursing program delivered online by Georgetown University’s renowned School of Nursing & Health Studies.
Our activities touch many lives
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. We discover, develop, manufacture and market prescription medicines for cancer, cardiovascular, gastrointestinal and infection. MORE

 Regenerative Medicine

'Fertilizing' bone marrow helps answer why some cancers hit bone
Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers found that administering a common chemotherapy drug before bone tumors took root actually fertilized the bone marrow, enabling cancer cells, once introduced, to seed and grow more easily. The findings provide valuable insight as to why some cancers metastasize to bone, and could eventually result in new metastasis-prevention drugs, one researcher said. More

Embryonic stem cells can be used to grown bone tissue grafts
The Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new study shows that human embryonic stem cells can be used to grow bone tissue grafts for use in research and potential therapeutic application. The study is the first example of using bone cell progenitors derived from human embryonic stem cells to grow compact bone tissue in quantities large enough to repair centimeter-sized defects. More

 Emerging Medical Technologies

Lawmakers say tax hurts growing bio-med industry
Ohio News Network    Share    Share on FacebookTwitterShare on LinkedinE-mail article
VideoBriefAn emerging industry in Ohio is looking forward to a bright future with great paying jobs, but they have concerns. Lawmakers and bio-medical industry leaders told ONN they are worried the federal government could slow that success. Bio-medical experts say the industry employs more than 35,000 Ohioans who make at least $65,000 a year. More

Ultrasensitive biosensor promising for medical diagnostics
R&D Magazine    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers have created an ultrasensitive biosensor that could open up new opportunities for early detection of cancer and "personalized medicine" tailored to the specific biochemistry of individual patients. The device, which could be several hundred times more sensitive than other biosensors, combines the attributes of two distinctly different types of sensors, researchers said. More

 Managed Healthcare News

Doctors and insurers are key to fighting obesity
Kaiser Health News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Doctors assess patients' breathing, heart rate and blood pressure routinely at office visits. Soon, they may be adding body mass index to that list. Tracking this measure — an indicator of whether someone is obese or overweight — as if it were a vital sign at medical checkups is among a new set of strategies recommended for battling obesity, a concern that some experts predict will affect 42 percent of adults by 2030. More

Catholic college drops health plan over contraception mandate
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A small Catholic college in Ohio is dropping health insurance coverage for students rather than comply with a federal mandate that the plan provide free birth control. The Franciscan University of Steubenville "will not participate in a plan that requires us to violate the consistent teachings of the Catholic Church on the sacredness of human life," according to a bulletin to students posted on the university's website. More

 FDA: New Treatments and Technology

FDA panel recommends approving home HIV test
CNN    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Consumers may soon be able to test themselves for HIV and quickly learn the results in the privacy of their own homes following a unanimous approval recommendation from a Food and Drug Administration advisory committee. The panel said the OraQuick In-Home HIV Test should be made available over-the-counter saying the test is safe and effective and that the benefits far outweigh the potential risks. More

FDA advisers back Pfizer arthritis drug
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Pfizer won support from a U.S. advisory panel for its arthritis drug, which the world's top drugmaker hopes will give it a major boost after a wave of patents expire. A panel of outside experts to the U.S. Food and Drug Administration voted to recommend approval of tofacitinib, a treatment for patients with rheumatoid arthritis who have not had success with at least one other drug for the disease. More

"The Centers for Disease Control and Prevention estimates more than one million people are living with HIV in the United States, and that 20 percent of those people living with it are unaware of their infection."
Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Christine Kraly, Content Editor, 469.420.2685   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
May 10, 2012
May 3, 2012
April 26, 2012
April 19, 2012

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063